Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carbonwave is a biotechnology company that specializes in the upcycling of Sargassum seaweed into sustainable, high-performance materials. Utilizing a proprietary biorefinery platform, the company produces the world's first seaweed-based cosmetic emulsifier, SeaBalance, which serves as a natural alternative to petroleum-derived ingredients. Beyond personal care, Carbonwave develops agricultural biostimulants and is researching advanced biopolymers for use in textiles and medical applications. The company's mission is to mitigate the environmental impact of invasive seaweed blooms while providing regenerative solutions for global industries. By transforming a climate threat into a resource, Carbonwave supports carbon sequestration and the transition to a circular economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carbonwave.